Credibility Analysis of Putative Disease-Causing Genes Using Bioinformatics

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Abel, Olubunmi ^a   Powell, John F ^b   Andersen, Peter M ^c,d   Al Chalabi, Ammar ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FUSED IN SARCOMA PROTEIN; TAR DNA BINDING PROTEIN;

ALS2 GENE; AMYOTROPHIC LATERAL SCLEROSIS; ANG GENE; ARTICLE; AUTOMATION; BIOINFORMATICS; CODON; CREDIBILITY ANALYSIS; DAO GENE; DCTN1 GENE; FIG4 GENE; FUS GENE; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC DATABASE; MUTATIONAL ANALYSIS; NEFH GENE; OPTN GENE; PATHOGENICITY; SETX GENE; SOD1 GENE; SPG11 GENE; STATISTICAL PARAMETERS; TAF15 GENE; TARDBP GENE; VAPB GENE; VCP GENE; ALLELE; BIOLOGICAL MODEL; BIOLOGY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; NONPARAMETRIC TEST; REPRODUCIBILITY; STATISTICAL MODEL;

ALLELES; AMYOTROPHIC LATERAL SCLEROSIS; COMPUTATIONAL BIOLOGY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; MODELS, STATISTICAL; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC;

EID: 84878750545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064899     Document Type: Article

References (26)

1. Charcot J, Joffroy A, (1869) Deux cas d'atrophie musculaire progressive. Arch Physiol Norm Pathol 2: 744-760.
2. Cleveland DW, Rothstein JD, (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience 2: 806-819.
3. Fong GCY, Kwok KHH, Song Y, Cheng T, Ho PWL, et al. (2006) Clinical phenotypes of a large Chinese multigenerational kindred with autosomal dominant familial ALS due to Ile149Thr SOD1 gene mutation. Amyotrophic Lateral Sclerosis 7: 142-149.
4. Eisen A, Mezei MM, Stewart HG, Fabros M, Gibson G, et al. (2008) SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethical issues in management. Amyotrophic Lateral Sclerosis 9: 108-119.
5. Byrne S, Walsh C, Lynch C, Bede P, Elamin M, et al. (2011) Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. Journal of Neurology, Neurosurgery and Psychiatry 82: 623.
6. Al-Chalabi A, Lewis CM, (2011) Modelling the effects of penetrance and family size on rates of sporadic and familial disease. Human Heredity 71: 281-288.
7. Hanby MF, Scott KM, Scotton W, Wijesekera L, Mole T, et al. (2011) The risk to relatives of patients with sporadic amyotrophic lateral sclerosis. Brain.
8. Al-Chalabi A, Leigh PN, (2005) Trouble on the pitch: are professional football players at increased risk of developing amyotrophic lateral sclerosis? Brain 128: 451.
9. Siddique T, Figlewigz DA, Pericak-Vance MA, Haines JL, Rouleau G, et al. (1991) Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. New England Journal of Medicine 324: 1381-1384.
10. Rosen D, Siddique T, Patterson D, Figlewicz D, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.
11. Lill CM, Abel O, Bertram L, Al-Chalabi A, (2011) Keeping up with genetic discoveries in amyotrophic lateral sclerosis: The ALSoD and ALSGene databases. Amyotrophic Lateral Sclerosis 12: 238-249.
12. Hamosh A, Scott A, Amberger J, Valle D, McKusick V, (2000) Online Mendelian Inheritance in Man (OMIM) Hum. Mutat 15: 57-61.
13. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 6: e1000097.
14. Andersen PM, Al-Chalabi A (2011) Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nature Reviews Neurology.
15. Thomas PD, Kejariwal A, Campbell MJ, Mi H, Diemer K, et al. (2003) PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Research 31: 334.
16. Ng PC, Henikoff S, (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Research 31: 3812.
17. Sunyaev S, Ramensky V, Koch I, Lathe W III, Kondrashov AS, et al. (2001) Prediction of deleterious human alleles. Human Molecular Genetics 10: 591.
18. Brooks BR, (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. Journal of the Neurological Sciences 124: 96.
19. Brooks BR, Miller RG, Swash M, Munsat TL, (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 1: 293.
20. Agency for Toxic Substances and Disease Registry (2011) National Amyotrophic Lateral Sclerosis (ALS) Registry.
21. David F, Mallows C, (1961) The variance of Spearman's rho in normal samples. Biometrika 48: 19-28.
22. Ramsey PH, (1989) Critical values for Spearman's rank order correlation. Journal of Educational and Behavioral Statistics 14: 245-253.
23. Yue S, Pilon P, Cavadias G, (2002) Power of the Mann-Kendall and Spearman's rho tests for detecting monotonic trends in hydrological series. Journal of Hydrology 259: 254-271.
24. Ioannidis J, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, et al. (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. International Journal of Epidemiology 37: 120.
25. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, et al. (2011) Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron.
26. Renton AE, Majounie E, Waite A, Simãn-Sãnchez J, Rollinson S, et al. (2011) A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron.